Curis Inc (CRIS)
11.28
+0.08
(+0.71%)
USD |
NASDAQ |
May 28, 11:46
Curis Cash from Investing (Quarterly): 18.91M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.91M |
| December 31, 2023 | 14.52M |
| September 30, 2023 | 0.18M |
| June 30, 2023 | -3.154M |
| March 31, 2023 | 26.24M |
| December 31, 2022 | 3.463M |
| September 30, 2022 | 4.303M |
| June 30, 2022 | 28.34M |
| March 31, 2022 | -3.083M |
| December 31, 2021 | -3.523M |
| September 30, 2021 | -11.53M |
| June 30, 2021 | -28.77M |
| March 31, 2021 | -4.071M |
| December 31, 2020 | -53.47M |
| September 30, 2020 | -0.162M |
| June 30, 2020 | -0.258M |
| March 31, 2020 | 4.841M |
| December 31, 2019 | 1.549M |
| September 30, 2019 | 1.453M |
| June 30, 2019 | -8.058M |
| March 31, 2019 | 0.60M |
| December 31, 2018 | 4.654M |
| September 30, 2018 | 4.679M |
| June 30, 2018 | 13.81M |
| March 31, 2018 | -1.773M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.571M |
| September 30, 2017 | 4.935M |
| June 30, 2017 | -6.012M |
| March 31, 2017 | 0.018M |
| December 31, 2016 | 14.06M |
| September 30, 2016 | 20.23M |
| June 30, 2016 | 5.127M |
| March 31, 2016 | -9.291M |
| December 31, 2015 | 15.66M |
| September 30, 2015 | 2.765M |
| June 30, 2015 | 15.73M |
| March 31, 2015 | -40.58M |
| December 31, 2014 | 5.254M |
| September 30, 2014 | 0.676M |
| June 30, 2014 | 6.902M |
| March 31, 2014 | 3.442M |
| December 31, 2013 | -5.928M |
| September 30, 2013 | -6.061M |
| June 30, 2013 | -2.892M |
| March 31, 2013 | 1.263M |
| December 31, 2012 | -11.74M |
| September 30, 2012 | -1.360M |
| June 30, 2012 | -2.260M |
| March 31, 2012 | -7.646M |
| December 31, 2011 | -6.052M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-53.47M
Minimum
Dec 2020
28.34M
Maximum
Jun 2022
-0.6139M
Average
0.009M
Median
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -0.158M |
| Perspective Therapeutics Inc | -47.30M |
| Protalix BioTherapeutics Inc | -0.606M |
| Electromed Inc | -0.129M |
| Armata Pharmaceuticals Inc | -0.25M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.23M |
| Cash from Financing (Quarterly) | -2.406M |
| Free Cash Flow | -39.47M |
| Free Cash Flow Per Share (Quarterly) | -2.288 |
| Free Cash Flow to Equity (Quarterly) | -13.23M |
| Free Cash Flow Yield | -63.28% |